Archit Organosys Limited has issued a corrigendum to its Annual General Meeting (AGM) notice, withdrawing three significant agenda items. The decision, approved by the Board of Directors on September 23, 2026, removes proposals related to capital increase, a major acquisition, and a preferential share issue from the meeting scheduled for September 30, 2026.

The withdrawn items were originally part of the AGM notice dated September 3, 2026. Item 8 proposed an increase in authorized share capital and consequent alteration of the Memorandum of Association. Item 9 sought approval for the acquisition of up to 1,36,24,172 equity shares, representing 67.44% of the equity share capital of Archit Life Science Limited, from its selling shareholders as a material related party transaction. Item 10 involved offering, issuing, and allotting equity shares on a preferential basis.

Withdrawn Agenda Items

The company stated that the respective explanatory statements for these items have also been withdrawn and will not form part of the business to be transacted at the AGM. The corrigendum ensures transparency regarding the revised scope of shareholder voting.

Remaining Business Matters

Except for the withdrawn items, all other terms and contents of the original AGM notice remain unchanged. Shareholders will still vote on ordinary business, including the adoption of audited financial statements for FY26, reappointment of Kandarp K. Amin, and declaration of a dividend of ₹1 per equity share. Special business items retained include ratification of cost auditor remuneration, approval of material related party transactions with Archit Life Science Limited, and approvals under Sections 185 and 186 of the Companies Act, 2013 for loans and investments.

The company has dispatched the corrigendum to all concerned shareholders. The updated notice is available on the company website and the NSDL e-voting portal. The remote e-voting period for the remaining resolutions begins on September 27, 2026, and ends on September 29, 2026.

Archit Organosys Ltd will hold its 33rd Annual General Meeting (AGM) on Wednesday, September 30, 2026. The meeting will be conducted through video conferencing or other audio-visual means, with remote e-voting facilities available for shareholders.

Meeting Details

The company announced the meeting pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was published in the Western Times newspaper on September 9, 2026.

Key Dates and Logistics

Shareholders holding shares in physical form can request login credentials by emailing share@architorg.com with their name, folio number, PAN, and Aadhaar card copies. Demat holders can request credentials via their depository participants or by emailing evoting@nsdl.co.in .

Voting and Record Dates

The company has appointed National Securities Depository Limited (NSDL) as the authorized agency for remote e-voting. The voting window will remain open for three days. Shareholders who vote remotely cannot vote again during the AGM.

The record date for determining dividend entitlements is Wednesday, September 23, 2026. The company’s share transfer books will remain closed from September 24, 2026, to September 29, 2026, inclusive.

What the Numbers Show

The announcement confirms the company’s adherence to regulatory timelines for its annual governance cycle. The decision to conduct the AGM virtually aligns with ongoing corporate practices for remote shareholder engagement, ensuring accessibility without requiring physical presence.